- Home
- / Vazyme
Vazyme
Stock Price
¥24.1
2024-10-29
Market Capitalization
¥9.4 B
2024-10-29
Revenue
¥1.4 B
FY, 2025
Vazyme Summary
Company Summary
- Overview
- Nanjing Vazyme Biotech (南京诺唯赞生物科技股份有限公司) is a biotechnology company that provides enzymes and antibodies solutions. It offers stabilizers, antigen detection and test kits, virus sampling tubes and extraction kits, thermal cyclers, and other products.
- Type
- Public
- Status
- Active
- Founded
- 2012
- HQ
- Nanjing, CN | view all locations
- Cybersecurity rating
Table of Contents
Key People
Xu Xiaoyu, Senior Vice President
Zhang Lijun, Senior Vice President
Tang Bo, Senior Vice President
LocationsView all
11 locations detected
Nanjing, Jiang Su Sheng HQ
China
Building D2. Red Maple Technology Industrial Park, Kechuang Road, Economy and Technology Development Zone
San Diego, CA
United States
9235 Activity Rd, Ste 101-102
Melbourne, VIC
Australia
Vancouver, BC
Canada
Nanjing
China
Floor 1-6, East Section, Building C1-2, Hongfeng Technology Park, Kechuang Road, Nanjing Economic and Technological Development Zone
Düsseldorf, NRW
Germany
Vazyme Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥317.1M
- Gross profit (Q1, 2026)
- ¥224.2M
- Net income (Q1, 2026)
- ¥2.0M
- Cash (Q1, 2026)
- ¥905.5M
- EBIT (Q1, 2026)
- ¥4.4M
- Enterprise value
- $9.5B